DCEG staff members often receive scientific and professional society awards and recognition. In addition, they present their research at scientific conferences and participate in other events. Read about current DCEG people in the news below, and view an archive of past people in the news.
In September, Martha S. Linet, M.D., M.P.H., Chief of the Radiation Epidemiology Branch, was honored with the Outstanding Contributions to Epidemiology Award at the annual meeting of the American College of Epidemiology (ACE). This award recognizes an active epidemiologist for outstanding contribution to the field in one of three areas: 1) methods; 2) etiologic research; or 3) applied epidemiology. View a list of DCEG speakers and participants at the meeting.
An independent panel of scientists from the National Academy of Sciences (NAS) has affirmed the National Toxicology Program’s 2011 classification of formaldehyde as a “known human carcinogen” in its 12th Report of Carcinogens (RoC). Read more about the NAS panel's findings on formaldehyde carcinogenicity.
In August, DCEG scientists participated in the 29th International Papillomavirus Conference in Seattle, Washington. The meeting highlighted basic, clinical, and public health science topics ranging from molecular virology to novel cancer screening and treatment strategies to global public health.
Aimée R. Kreimer, Ph.D., presented a plenary talk on “Oral HPV natural history and its progression to oropharyngeal cancer.” View a list of other DCEG speakers and participants at the conference.
In July, Christian C. Abnet, Ph.D., M.P.H., was named Acting Chief of the Nutritional Epidemiology Branch (NEB). Dr. Abnet joined NCI as a Cancer Prevention Fellow in 1998, became a tenure-track investigator in NEB in 2005, and was awarded tenure in May 2014.
Over the past 14 years, researchers in the Clinical Genetics Branch (CGB), led by Branch Chief Sharon Savage, M.D., have carried out a study of dyskeratosis congenita (DC) at the NIH Clinical Center to better understand the disorder and to identify the genes responsible for it.
Using exome sequencing, Dr. Savage and her team have identified several genes that cause DC, including RTEL1, a gene known to be involved in telomere biology. Discovery of a rare founder mutation in this gene has led to a direct benefit for at least one DC family. Read more about this discovery.